ASCO 2026: Highlights and analysis
ASCO 2026: Highlights and analysis
Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases
Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer
Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases
Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-invasive bladder cancer
AMVAC plus nivolumab in muscle-invasive bladder cancer preserves bladder and predicts metastatic control with ctDNA
225Ac-PSMA-trillium shows high PSA response and favourable safety in metastatic castration-resistant prostate cancer
Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns
DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing cytoreductive surgery
From lived experience to informed choice in breast cancer reconstruction
Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative breast cancer after 5 years
IPSO guidelines on minimally invasive surgery in paediatric solid tumours